KNORR-BREMS Research Development from 2010 to 2026

KBXA Stock  EUR 25.80  1.00  3.73%   
KNORR-BREMS UNSPADRS1/4's Research Development is increasing over the last several years with slightly volatile swings. Research Development is predicted to flatten to about 65.1 M. During the period from 2010 to 2026 KNORR BREMS UNSPADRS14 Research Development regressed destribution of quarterly values had coefficient of variationof  19.90 and r-value of  0.72. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
84 M
Current Value
65.1 M
Quarterly Volatility
10.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check KNORR-BREMS UNSPADRS1/4 financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among KNORR-BREMS UNSPADRS1/4's main balance sheet or income statement drivers, such as Tax Provision of 156.2 M, Interest Income of 43.3 M or Interest Expense of 86.5 M, as well as many indicators such as . KNORR-BREMS financial statements analysis is a perfect complement when working with KNORR-BREMS UNSPADRS1/4 Valuation or Volatility modules.
  
This module can also supplement various KNORR-BREMS UNSPADRS1/4 Technical models . Check out the analysis of KNORR-BREMS UNSPADRS1/4 Correlation against competitors.
The Research Development trend for KNORR BREMS UNSPADRS14 offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether KNORR-BREMS UNSPADRS1/4 is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest KNORR-BREMS UNSPADRS1/4's Research Development Growth Pattern

Below is the plot of the Research Development of KNORR BREMS UNSPADRS14 over the last few years. It is KNORR-BREMS UNSPADRS1/4's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in KNORR-BREMS UNSPADRS1/4's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

KNORR-BREMS Research Development Regression Statistics

Arithmetic Mean53,925,376
Geometric Mean53,088,667
Coefficient Of Variation19.90
Mean Deviation8,046,458
Median48,249,000
Standard Deviation10,733,018
Sample Variance115.2T
Range35.7M
R-Value0.72
Mean Square Error59.3T
R-Squared0.52
Significance0
Slope1,529,263
Total Sum of Squares1843.2T

KNORR-BREMS Research Development History

202665.1 M
202584 M
202473 M
202362 M
202253.6 M

About KNORR-BREMS UNSPADRS1/4 Financial Statements

KNORR-BREMS UNSPADRS1/4 stakeholders use historical fundamental indicators, such as KNORR-BREMS UNSPADRS1/4's Research Development, to determine how well the company is positioned to perform in the future. Although KNORR-BREMS UNSPADRS1/4 investors may analyze each financial statement separately, they are all interrelated. For example, changes in KNORR-BREMS UNSPADRS1/4's assets and liabilities are reflected in the revenues and expenses on KNORR-BREMS UNSPADRS1/4's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in KNORR BREMS UNSPADRS14. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development84 M65.1 M

Currently Active Assets on Macroaxis

Other Information on Investing in KNORR-BREMS Stock

KNORR-BREMS UNSPADRS1/4 financial ratios help investors to determine whether KNORR-BREMS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KNORR-BREMS with respect to the benefits of owning KNORR-BREMS UNSPADRS1/4 security.